Filing Details
- Accession Number:
- 0001209191-19-049226
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-11 18:42:16
- Reporting Period:
- 2019-09-10
- Accepted Time:
- 2019-09-11 18:42:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1595893 | Turning Point Therapeutics Inc. | TPTX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1595117 | Simeon George | C/O S.r.one, Limited 161 Washington Street, Suite 500 Conshohocken PA 19428 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-09-10 | 177,777 | $45.00 | 2,170,327 | No | 4 | P | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See Footnote |
Footnotes
- Reflects shares of Common Stock of Turning Point Therapeutics, Inc (the "Issuer") that were purchased by S.R. One, Limited in connection with the Issuer's public offering.
- S.R. One, Limited, an indirect, wholly-owned subsidiary of GlaxoSmithKline plc, is the record holder of these shares reported herein. Simeon J. George is the Chief Executive Officer, President and a Member of the Board of Trustees at S.R. One, Limited and an employee of GlaxoSmithKline LLC, an indirect, wholly-owned subsidiary of GlaxoSmithKline plc. Mr. George disclaims beneficial ownership of all shares held by S.R. One, Limited and this report shall not be deemed an admission of beneficial ownership of such shares for the purpose of Section 16 or for any other purpose except to the extent of his pecuniary interest therein.
Billionaire Hedge Funds
